Allspring Global Investments’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,049
| Closed | -$15.8K | – | 2489 |
|
|
2024
Q3 | $15.8K | Buy |
+3,049
| New | +$15.8K | ﹤0.01% | 2044 |
|
|
2023
Q4 | – | Sell |
-4,424
| Closed | -$50.7K | – | 2800 |
|
|
2023
Q3 | $50.7K | Sell |
4,424
-1,126,937
| -100% | -$12.9M | ﹤0.01% | 2266 |
|
|
2023
Q2 | $28.6M | Sell |
1,131,361
-405,889
| -26% | -$10.3M | 0.05% | 503 |
|
|
2023
Q1 | $49.5M | Buy |
1,537,250
+442,726
| +40% | +$14.3M | 0.08% | 335 |
|
|
2022
Q4 | $20.2M | Buy |
1,094,524
+508,249
| +87% | +$9.38M | 0.03% | 581 |
|
|
2022
Q3 | $15.8M | Buy |
586,275
+585,888
| +151,392% | +$15.8M | 0.03% | 625 |
|
|
2022
Q2 | $5K | Sell |
387
-1,618
| -81% | -$20.9K | ﹤0.01% | 2617 |
|
|
2022
Q1 | $39K | Buy |
2,005
+130
| +7% | +$2.53K | ﹤0.01% | 2875 |
|
|
2021
Q4 | $30K | Buy |
+1,875
| New | +$30K | ﹤0.01% | 2885 |
|